Syndax Pharmaceuticals Inc (SNDX)
Retained Earnings
-$1.60B
Quarterly · Period ending: · USD
SNDX Retained Earnings
Latest reported-$1.60Bperiod ending
Latest reported-$1.60Bperiod ending
SNDX Quarterly Retained Earnings (-$79.05K → -$1.60B)
Quarterly retained earnings
High-resolution chart · PNG
SNDX retained earnings history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -1,598,616,000 | |
| -1,549,253,000 | |
| -1,506,580,000 | |
| -1,438,566,000 | |
| -1,377,851,000 | |
| -1,306,004,000 | |
| -1,221,158,000 | |
| -1,126,989,000 | |
| -1,042,863,000 | |
| -974,800,000 | |
| -902,400,000 | |
| -829,927,000 | |
| -778,781,000 | |
| -734,166,000 | |
| -693,040,000 | |
| -653,846,000 | |
| -618,443,000 | |
| -580,871,000 | |
| -543,702,000 | |
| -639,900,000 | |
| -619,261,000 | |
| -596,351,000 | |
| -568,628,000 | |
| -548,205,000 | |
| -527,768,000 | |
| -510,706,000 | |
| -495,470,000 | |
| -481,470,000 | |
| -468,641,000 | |
| -453,725,000 | |
| -439,423,000 | |
| -420,586,000 | |
| -403,247,000 | |
| -384,860,000 | |
| -366,111,000 | |
| -347,008,000 | |
| -331,919,000 | |
| -318,279,000 | |
| -305,293,000 | |
| -294,478,000 | |
| -279,509,000 | |
| -271,151,000 | |
| -259,675,000 | |
| -252,087,000 | |
| 0 | |
| -159,801,000 | |
| -155,018,000 | |
| -146,484,000 | |
| -140,732,000 | |
| -135,707,000 | |
| -124,476,000 | |
| 0 | |
| -79,054 |